The medicament production market in Germany focused on products containing hormones but not antibiotics is forecasted to see a gradual increase over the next five years from 2024 to 2028. In 2023, the market stood at 1.6020 billion euros. Year-on-year growth suggests steady rises averaging around 1.85% through 2028, with a CAGR of approximately 1.92% during this period.

Future trends to consider include:

Potential regulatory changes impacting production processes and costs.
Innovations in drug delivery technologies, potentially increasing demand.
Health trends influencing consumer preferences towards hormone-based medicaments.